Opvolger Executive Committee Nobel Biocare

 

1 december 2010 - Nobel Biocare heeft vandaag diverse namen van benoemingen bekend gemaakt, waaronder een opvolger in de Executive Committee. Hieronder treft u het originele bericht aan.

Nobel Biocare announced today that Bill Ryan, after successfully transforming the North American organization, will revert back to his original role as an advisor to the CEO. In addition, he will become non-executive Chairman North America. In these roles Bill Ryan will, with his more than 25 years of experience in implant dentistry, continue to support the company. Melker Nilsson will succeed Bill Ryan as President & General Manager North America and as a member of Nobel Biocare’s Executive Committee (EC). At present, Melker Nilsson is Chief Operating Officer North America. Melker has more than 18 years of experience in implant dentistry and with NobelProcera, which he gained through various management assignments at Nobel Biocare in Europe and North America from 1992 through 2005. He rejoined Nobel Biocare in his current position in January 2010. Melker Nilsson is a Swedish citizen and holds a master’s degree in law from Lund University in Sweden. Both appointments are effective as of 1 January 2011.

The company also announced today the appointment of Mike Thompson as Senior Vice President & General Manager Asia/Pacific. Mike joins Nobel Biocare from Pfizer, where he held various management positions in sales, marketing and human resources in the US, China and Japan. Mike is a graduate in Chinese and Asian studies and holds a master’s degree in international management from Thunderbird. He is a US citizen and has a fluent command of the Chinese language and is conversant in Japanese. He will succeed Tom Olsen, who after 10 years in this position will become Executive Vice President of Sales for North America and report to Melker Nilsson. Tom has more than 20 years of experience in implant dentistry with various assignments in Europe, Asia and the US. Both appointments will become effective 1 January 2011.

In addition, the company appointed General Counsel Jörg von Manger-Koenig as Head of Legal & Compliance and member of the EC. In this newly created function, Jörg will be responsible for legal matters, regulatory issues and quality assurance. He holds a degree in law from the University of Bonn, Germany, and joined Nobel Biocare in 2007. Jörg von Manger-Koenig will remain Secretary of the Board of Directors of Nobel Biocare Holding AG. This appointment will also take effect as of 1 January 2011.

Domenico Scala, CEO, said: “These appointments, of individuals that have a strong track record and the necessary experience in the dental field, demonstrate our successful succession planning. Bill and Melker have substantially strengthened our North American organization over the last 15 months. Tom has successfully led Asia during a period of strong growth and Mike brings extensive experience of the Asian markets and its diverse cultures. Jörg will continue to strengthen our compliance culture and our dedication to quality.”

Terug naar home